(Total Views: 488)
Posted On: 02/22/2021 5:37:20 PM
Post# of 156316
Re: generactor #79336
Quote:
Nader has not been known to show restraint when given the chance to hype the company, and the CD12 topline results would be the ultimate opportunity to do so.
Is it possible they received the unblinded data which they shared with the FDA at its request, but they haven't received the top line results yet? A cursory review would show them if the results were good knowing that it would be premature to shout it from the roof tops.
(4)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
